Schizophrenia is a complex and heterogenous psychiatric disorder. This study aimed to
demonstrate the potential of circulating microRNAs (miRNAs) as a clinical biomarker to …

Based on our previous finding of a seven-miRNA (hsa-miR-34a, miR-449a, miR-564, miR-
432, miR-548d, miR-572 and miR-652) signature as a potential biomarker for schizophrenia …

Since brain tissue is not readily accessible, a new focus in search of biomarkers for
schizophrenia is blood-based expression profiling of non-protein coding genes such as …

MicroRNAs (miRNA, miR) have been implicated as promising blood‐based biomarkers for
schizophrenia patients. This study aimed to clinically validate miRNA as potential …

Background Schizophrenia (SZ), a complex and chronic neuropsychiatric disorder affecting
approximately 1% of the general population, presents diagnostic challenges due to the …

Findings from multiple studies on microRNA (miRNA) expression profiling in schizophrenia
patients have produced conflicting results. In order to investigate miRNA as specific …

Background Recent studies on the schizophrenia spectrum and other psychotic disorders
showed that alternation of immune system components, particularly microRNAs (miRNAs) …

Alterations in microRNAs (miRNAs) have been considered to have diagnostic implications in
most diseases, but few studies have reported dysregulated miRNAs in schizophrenia (SCZ) …

Schizophrenia (SCZ) is a severe psychiatric disorder with unclear pathophysiology.
Moreover, there is no specific biological marker to help clinicians to define a diagnosis, and …

Schizophrenia is a serious mental disease that is regulated by multiple genes and
influenced by multiple factors. Due to the complexity of its etiology, the pathogenesis is still …